The stock gained 2 per cent to settle at Rs 1,060.60 on BSE. During the day, it rose by 2.99 per cent to Rs 1,070.95.
Lupin was the best performer among the 30-share index.
At NSE, shares of the company advanced by 2.12 per cent to close at Rs 1,062.
The company has launched Hydrocodone Bitartrate and Acetaminophen tablets USP in the strengths of 5mg/325 mg, 7.5 mg/325 mg and 10mg/325 mg after receiving approval from the US Food and Drug Administration (USFDA), Lupin said in a BSE filing.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)